In addition to an association of heparanase with myeloma progression, Bret and colleagues discovered that Sulf2 expression in primary multiple myeloma cells were associated with a poor prognosis in two independent large cohorts of patients. This evidence concerns the gene HPSE and AL amyloidosis.